Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: Topical Raplixa for Surgical Bleeding in Children [Phase 2]

View source ↗

Summary

Phase 2 trial update for topical Raplixa in surgical bleeding outcomes in children; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raplixa (TachoSil? Wait Raplixa is fibrin sealant containing human thrombin and fibrinogen known as Raplixa (topical tranexamic?))

Snippet

Sponsor: Mallinckrodt | Conditions: Surgical Bleeding | Phase 2 | Status: TERMINATED | Results posted: 2020-02-05